Kristin Gusack is joined by Dr. Marie McDonnell, the Chief of the Diabetes Section and Director at Brigham Health Diabetes Program at Harvard Medical School in Boston, MA. The discussion covers teleconference-specific communications skills in diabetes management, strategies for pharmacotherapy management and devices that can be used to manage patients with diabetes as their needs evolve, strategies for treatment adherence, and identification of potentially underserved populations.
This podcast reviews teleconference-specific communication skills in diabetes management, discusses strategies for pharmacotherapy management and devices that can be used to manage patients with diabetes as their needs evolve, considers strategies for treatment adherence, and identifies potentially underserved populations.
Marie McDonnell, MD
Chief of Diabetes Section
Division of Endocrinology, Diabetes, and Hypertension
Director, Brigham Health Diabetes program
Brigham and Women’s Hospital
Harvard Medical School
This activity is intended for endocrinologists, primary care physicians, nurses, nurse practitioners, physician assistants, diabetes educators and other allied healthcare professionals who manage patients with diabetes.
After completing this activity, the participant should be better able to:
|•||Demonstrate teleconference-specific communication skills: how to behave naturally, professionally and persuasively, with comparable levels of empathy, patient-teaching potential and amount of information provided comparable to in-person encounters.|
|•||Apply strategies for using telemedicine and telemonitoring to improve medication adherence and treatment plan adherence, including switching strategies among patients with diabetes.|
|•||Compare and contrast the various pharmacotherapies and devices that can be used to manage patients with diabetes in light of changed patient management conditions.|
Providership, Credit, and Support
This episode is a collaboration between the Endocrine Society and Medical Learning Institute, Inc.
Physician Continuing Medical Education
The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.
Nursing Continuing Professional Development
Medical Learning Institute, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Successful completion of this nursing continuing professional development activity will be awarded 0.5 contact hours and 0.12 contact hour in the area of pharmacology.
This activity is supported by an independent educational grant from Merck & Co., Inc.
Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc. (MLI) and the Endocrine Society (ES) requires faculty, planners, staff, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. These disclosures will be provided to learners prior to the start of the activity. All identified COI are thoroughly vetted and resolved according to ES and MLI policy. ES and MLI is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Marie McDonnell, MD has a financial interest/relationship or affiliation in the form of Advisory Board/Consulting fees from Everlywell, Inc and a stockholder of Abbott Industries.
The following Content Reviewers have nothing to disclose:
Tracy Greene, MSN, RN, FNP-C, Lead Nurse Planner
Bobbie Perrin, APRN, FNP-C
Beret A. Casey, MD
The planners from the Endocrine Society and Medical Learning Institute, Inc., do not have any financial relationships with an ACCME-defined commercial interest related to the content of this accredited activity during the past 12 months unless listed below.
Diclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this accredited activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain NCPD credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Accredited CE Activity Release Date: March 4, 2021
Accredited CE Activity Expiration Date: March 3, 2022
Time to complete activity: 30 minutes
Listen in to the episode!
Opt-in to the email notification list.
Once you have listened to the episode, click on the button below to be directed to the evaluation and application for credit. Once you have successfully completed the evaluation/posttest, your certificate will be emailed to you. Please allow up to 5 business days to receive your certificate.